Lavender Sky Health Tirzepatide Review

Lavender Sky Health price at every dose tier

This is the table that decides your year. The advertised figure applies to the starter dose you occupy for roughly four weeks; the row to budget from is 10 mg.

Where Lavender Sky Health sits in the market

On first-year cost it ranks 9 of 16. The cheapest priced route, NexLife, comes in about $1,391 lower over the same year. Whether that gap is worth paying depends on what this programme provides that the cheaper one does not, which is a question about disclosure and service rather than about the molecule.

What Lavender Sky Health discloses before you pay

Pharmacy: not published. Visit model: not published. Laboratory requirement: not published. Coaching: not published. Cancellation: not published.

Naming the dispensing pharmacy is the single most useful disclosure a programme can make, because it is the one fact that lets you check a state board register yourself before injecting anything weekly. Fewer than a fifth of the programmes we track publish it.

Who should not choose Lavender Sky Health

Anyone likely to escalate to 12.5 or 15 mg, because the rate rises with you and flat-rate programmes overtake this one at the top of the ladder. Anyone who needs an FDA-approved product, since this is a compounded preparation that FDA does not review for safety, effectiveness or quality before marketing. And anyone who cannot get a straight answer to the pharmacy question.

How the price behaves as your dose climbs

Lavender Sky Health starts at $200 and rises with your prescription, reaching $352 at 10 mg. The advertised figure therefore describes roughly four weeks of a twelve-month course. Budget from the 10 mg row, because that is where most of your year happens.

Dose-scaled pricing is not misconduct — more active drug does cost a compounder more. But it means your bill rises exactly as the dose starts working, which inverts the incentive you face and is invisible in any table quoting one number.

What a longer horizon costs here

Treatment on this drug class is realistically a multi-year commitment, because the withdrawal evidence shows substantial regain after stopping. These are the numbers worth deciding on.

Commitment, refunds and what is at risk

No discounted prepaid term is published, which cuts both ways: no lower rate for committing, and no money at risk before you know whether you tolerate the drug. For a first three months that is the safer structure.

Cancellation: not published. Two questions to get in writing before paying anything: does the quoted rate hold at renewal, and what happens if a clinician stops your prescription mid-term.

What this programme does not publish

Measured against our published criteria, Lavender Sky Health does not publish: price does not rise as the dose escalates; dispensing pharmacy or prescriber named before purchase; no separate recurring membership fee; prepaid term and its rate published; state availability published; cancellation terms published. Each is a question you can ask before enrolling, and a programme that answers in writing has told you something useful about how it operates.

Naming the dispensing pharmacy carries the most weight of the seven, because it is the only one that lets you check a public state board register yourself before injecting something weekly. Fewer than a fifth of the programmes we price do it.

Seven questions before you enrol

1. What is the total in month six at 10 mg, including every fee?
2. Which compounding pharmacy fills the prescription, by name and state licence?
3. Is the prescribing clinician licensed in my state?
4. What is the vial concentration and the beyond-use date?
5. Does the quoted rate hold at renewal, or revert?
6. What happens if a shipment arrives warm, and who pays for the replacement?
7. What notice is required to cancel, and what is refundable before shipment?

None requires clinical training and all are answerable before you pay. A programme that deflects the pharmacy question has answered it.

Using it well if you do enrol

Fix a weekly injection day and keep it. Record dose, date and injection site each week. Photograph any shipment that arrives warm before opening it further. Diary the renewal date if an introductory rate applies. And re-price the market annually at your actual maintenance dose — no programme tells existing patients when a competitor drops below it.

What Lavender Sky Health costs at each maintenance dose, over three years

Nobody knows their maintenance dose at intake, so a single annual figure is a guess about a decision a prescriber has not made. This is every plausible outcome for Lavender Sky Health, priced.

The spread between the cheapest and dearest outcome here is $2,436 a year. That is the amount riding on a clinical decision you do not control, which is the argument for reading the pricing model before the headline number.

Where every dollar goes at Lavender Sky Health

At a 10 mg maintenance dose the $352 you pay splits into $327 of medication and dispensing plus $25 of recurring platform fee.

Over twelve months the platform fee alone is $300, and over three years $900. A comparison quoting only the medication figure understates this programme by exactly that much — not once, but every month you stay enrolled.

What the figure does not include: laboratory work if the programme requires it, expedited shipping surcharges, and anything billed irregularly. Those are priced separately on the hidden-fee checklist rather than folded into a monthly number, because folding irregular charges into a recurring figure would be its own distortion.

How many programmes beat Lavender Sky Health on a first year

8 of the 15 other priced programmes come in below Lavender Sky Health over a first year; 7 come in above. The cheapest is NexLife at $2,580, a difference of $1,391.

Whether that gap is worth paying turns on what Lavender Sky Health provides that the cheaper route does not. Compare the disclosure rows rather than the price rows: pharmacy identity, prescriber licensure, cancellation terms and whether the quoted rate holds at renewal.

Bear in mind that 15 tracked programmes publish no price at all. They are not cheaper or dearer; they are unmeasurable, and their pages say so rather than carrying an estimate.

What escalation costs at Lavender Sky Health, in dollars

From $200 at initiation to $454 at the ceiling: a $254 monthly increase, $3,048 across a year and $9,144 over three.

It lands at the worst moment. Mean weight reduction rose across the studied 5, 10 and 15 mg maintenance arms in the pivotal programme, so the doses most likely to work are the doses this model charges most for. A patient responding well is a patient whose bill is climbing, and that is invisible in any table quoting one number.

If you expect to hold low, this structure may beat a flat programme. If you expect to escalate, run the first-year calculator at your expected dose before enrolling.

Cost by maintenance dose and duration

A single annual figure assumes one maintenance dose, and nobody knows theirs at intake. This is what Lavender Sky Health costs across every plausible outcome over one, two and three years. The withdrawal evidence for this drug class shows substantial regain after stopping, so three years is a more honest planning horizon than twelve months.

How the price behaves as your dose climbs

Lavender Sky Health starts at $200 and rises with your prescription: about $352 at 10 mg and $454 at the ceiling. The advertised figure therefore describes roughly four weeks of a twelve-month course.

Between starter dose and ceiling the monthly bill moves by $254 — $3,048 across a year and $9,144 over three. Nobody knows at intake which row they will occupy, which is the structural problem with dose-scaled pricing: you are quoted a price for a decision your prescriber has not made yet.

The increase also lands at the worst moment. Mean weight reduction rose across the studied 5, 10 and 15 mg maintenance arms in the pivotal programme, so the doses most likely to produce a strong response are the doses this model charges most for.

What is bundled and what is billed separately

Lavender Sky Health splits the charge: medication plus $25 a month for the platform. Whether that earns its cost depends on whether you use it. Unlimited clinician messaging is genuinely valuable during titration and close to idle at stable maintenance.

Over a year the membership alone is $300; over three, $900. That is what a comparison quoting the medication figure alone understates this programme by — permanently, not once.

Ask in writing what happens to your prescription if the membership lapses mid-supply. If medication stops, a business model is imposing itself on a clinical relationship.

Commitment, refunds and what is recoverable

No discounted prepaid term is published for Lavender Sky Health, which cuts both ways. You are not offered a lower rate for committing, and you are not asked to put a four-figure sum at risk before knowing whether you tolerate a maintenance dose.

For a first three months that is the safer structure. For a stable long-term patient it leaves a discount on the table that several competitors offer.

Lavender Sky Health against the programmes priced closest to it

Comparing against the whole market is noise. Comparing against the three routes nearest your price point is a decision, because those are the programmes a real shopper is weighing.

Pausing or restarting

Pausing costs more than it looks, and the cost is clinical before it is financial. Stop for a month and appetite returns before the metabolic adaptation to a lower weight does; stop for several and most prescribers restart low and re-titrate.

On this pricing, re-titration means two months back at $200 and $251 — cheaper per month than maintenance, but you are paying for weeks that reproduce progress you had already made.

If cost is the reason for a pause, price the market before stopping. The cheapest tracked route, NexLife, runs about $2,580 a year against $3,971 here. Switching is almost always better than interrupting, because the interruption is what undoes the result.

Switching to or from this programme

Moving means a new clinical review and two risks worth planning around: a supply gap while an intake is processed, and a new prescriber restarting titration rather than continuing your dose. Do not cancel anything until the new programme has shipped.

Ask for dose continuity in writing before you move. Most programmes continue an established patient after review; the ones that will not are exactly the ones that will not say so until you have already cancelled.

Take three things with you: your current dose and the date you reached it, the concentration printed on your current vial, and any record of adverse effects with dates. Vial concentrations are not standardised between compounders, so carrying dosing instructions from an old vial to a new one is a genuine hazard rather than a theoretical one.

Eight questions to ask before you enrol

1. What will I pay in total in month six at 10 mg, including every fee?
2. Which compounding pharmacy fills the prescription, by name and state licence?
3. Is the prescribing clinician licensed in my state, and can I have their name?
4. What is the vial concentration, and what is the beyond-use date?
5. Does the quoted rate hold at renewal, or does it revert?
6. What happens if a shipment arrives warm, and who pays for the replacement?
7. What notice is required to cancel before the next cycle, and what is refundable?
8. Will you continue me at my current dose if I transfer in, or restart titration?

None requires clinical training to evaluate and all are answerable in writing. A programme that answers all eight is behaving well. A programme that deflects the pharmacy question has told you what you needed to know, and no headline number compensates for it.

What this programme discloses before you pay

Pharmacy: not published. Visit model: not published. Laboratory requirement: not published. Coaching: not published. Cancellation: not published.

Naming the dispensing pharmacy is the most useful disclosure any programme can make, because it is the one fact that lets you check a public state board register before injecting something weekly. Fewer than a fifth of the programmes we price publish it, and those that do are not systematically more expensive.

None of this measures clinical quality. A programme can name six pharmacies and ship late; another can name none and employ careful clinicians. What disclosure measures is how much you can verify before handing over money and a medical history.

What would change our record

A published price at a dose tier currently blank. A named dispensing pharmacy with a checkable state licence. A change to the pricing model in either direction. Or a correction from a reader or from the programme itself with a source we can check.

All four are logged with the date they changed, and the underlying record sits in the open dataset rather than locked inside a page. We do not accept payment to change any of it, and no programme has editorial input here.

Using this programme well if you do enrol

Fix a weekly injection day and keep it. Record the dose, date and injection site each week. Photograph any shipment that arrives warm before opening it further. Diary the renewal date if there is an introductory rate.

And re-price the market annually at your actual maintenance dose. No programme tells its existing patients when a competitor drops below it, and the cheapest tracked route currently sits at $215 a month all-in.

Where Lavender Sky Health sits in that spread

At $352 a month all-in at a 10 mg maintenance dose, Lavender Sky Health is about 64% above the cheapest tracked route, NexLife, at $215. Over a first year that is $3,971 against $2,580.

Whether the difference is worth paying is a question about what this programme provides that the cheaper one does not, and about how much of that you will use. It is not a question about the medicine, which is the same molecule from the same category of licensed pharmacy.

How the price behaves as your dose climbs

Lavender Sky Health starts at $200 and rises with your prescription, reaching $352 at 10 mg. The advertised figure therefore describes roughly four weeks of a twelve-month course. Budget from the 10 mg row, because that is where most of your year happens.

Dose-scaled pricing is not misconduct — more active drug does cost a compounder more. But it means your bill rises exactly as the dose starts working, which inverts the incentive you face and is invisible in any table quoting one number.

What a longer horizon costs here

Treatment on this drug class is realistically a multi-year commitment, because the withdrawal evidence shows substantial regain after stopping. These are the numbers worth deciding on.

Commitment, refunds and what is at risk

No discounted prepaid term is published, which cuts both ways: no lower rate for committing, and no money at risk before you know whether you tolerate the drug. For a first three months that is the safer structure.

Cancellation: not published. Two questions to get in writing before paying anything: does the quoted rate hold at renewal, and what happens if a clinician stops your prescription mid-term.

What this programme does not publish

Measured against our published criteria, Lavender Sky Health does not publish: price does not rise as the dose escalates; dispensing pharmacy or prescriber named before purchase; no separate recurring membership fee; prepaid term and its rate published; state availability published; cancellation terms published. Each is a question you can ask before enrolling, and a programme that answers in writing has told you something useful about how it operates.

Naming the dispensing pharmacy carries the most weight of the seven, because it is the only one that lets you check a public state board register yourself before injecting something weekly. Fewer than a fifth of the programmes we price do it.

Seven questions before you enrol

1. What is the total in month six at 10 mg, including every fee?
2. Which compounding pharmacy fills the prescription, by name and state licence?
3. Is the prescribing clinician licensed in my state?
4. What is the vial concentration and the beyond-use date?
5. Does the quoted rate hold at renewal, or revert?
6. What happens if a shipment arrives warm, and who pays for the replacement?
7. What notice is required to cancel, and what is refundable before shipment?

None requires clinical training and all are answerable before you pay. A programme that deflects the pharmacy question has answered it.

Using it well if you do enrol

Fix a weekly injection day and keep it. Record dose, date and injection site each week. Photograph any shipment that arrives warm before opening it further. Diary the renewal date if an introductory rate applies. And re-price the market annually at your actual maintenance dose — no programme tells existing patients when a competitor drops below it.

What Lavender Sky Health costs at each maintenance dose, over three years

Nobody knows their maintenance dose at intake, so a single annual figure is a guess about a decision a prescriber has not made. This is every plausible outcome for Lavender Sky Health, priced.

The spread between the cheapest and dearest outcome here is $2,436 a year. That is the amount riding on a clinical decision you do not control, which is the argument for reading the pricing model before the headline number.

Where every dollar goes at Lavender Sky Health

At a 10 mg maintenance dose the $352 you pay splits into $327 of medication and dispensing plus $25 of recurring platform fee.

Over twelve months the platform fee alone is $300, and over three years $900. A comparison quoting only the medication figure understates this programme by exactly that much — not once, but every month you stay enrolled.

What the figure does not include: laboratory work if the programme requires it, expedited shipping surcharges, and anything billed irregularly. Those are priced separately on the hidden-fee checklist rather than folded into a monthly number, because folding irregular charges into a recurring figure would be its own distortion.

How many programmes beat Lavender Sky Health on a first year

8 of the 15 other priced programmes come in below Lavender Sky Health over a first year; 7 come in above. The cheapest is NexLife at $2,580, a difference of $1,391.

Whether that gap is worth paying turns on what Lavender Sky Health provides that the cheaper route does not. Compare the disclosure rows rather than the price rows: pharmacy identity, prescriber licensure, cancellation terms and whether the quoted rate holds at renewal.

Bear in mind that 15 tracked programmes publish no price at all. They are not cheaper or dearer; they are unmeasurable, and their pages say so rather than carrying an estimate.

What escalation costs at Lavender Sky Health, in dollars

From $200 at initiation to $454 at the ceiling: a $254 monthly increase, $3,048 across a year and $9,144 over three.

It lands at the worst moment. Mean weight reduction rose across the studied 5, 10 and 15 mg maintenance arms in the pivotal programme, so the doses most likely to work are the doses this model charges most for. A patient responding well is a patient whose bill is climbing, and that is invisible in any table quoting one number.

If you expect to hold low, this structure may beat a flat programme. If you expect to escalate, run the first-year calculator at your expected dose before enrolling.

Where Lavender Sky Health lands on price

Lavender Sky Health sits 9 of 16 on first-year all-in cost, at $352 a month all-in at a 10 mg maintenance dose and about $3,971 across a first year including titration. That is $1,391 more than NexLife across a first year, a 54% premium, and above the $349 median monthly figure.

8 programmes we track come in cheaper on a first-year basis. That is worth stating plainly on a page about Lavender Sky Health: if price is the only criterion, this is not the answer, and the cheaper options are listed at the price index.

What the dose ladder costs at Lavender Sky Health

Lavender Sky Health prices by dose. The 2.5 mg starter dose is $200 a month and 15 mg is $454, a spread of $254 between the figure that attracts you and the figure you may end up paying.

Tirzepatide titrates in 2.5 mg steps at intervals of at least four weeks, and repeats are common. Most of a first year is spent at or near maintenance rather than at the starter dose, which is why we quote $352 at 10 mg rather than $200. If your prescriber settles you at 15 mg, the number becomes $454 and the first-year total moves accordingly.

The $25 membership at Lavender Sky Health

Lavender Sky Health bills a mandatory $25 monthly membership on top of medication. Our $352 figure includes it; the programme's own marketing generally quotes the medication component alone, which is $327.

Across a first year the membership alone is $300. That is not hidden — it is disclosed — but it is quoted separately, and separate quotation is how a $352 programme gets advertised as a $327 one.

Semaglutide at Lavender Sky Health, for comparison

Lavender Sky Health also dispenses compounded semaglutide at $174 a month all-in, $178 below its tirzepatide price — a 51% difference for the other molecule at the same programme, the same clinicians and the same fulfilment.

That gap is close to the market norm and it is structural. Semaglutide is a shorter peptide with a longer manufacturing history and more compounding pharmacies equipped to produce it; tirzepatide is harder to synthesise and its active ingredient sells at a premium. Neither figure is subsidising the other.

Whether the tirzepatide premium is worth $2,136 across a year is a clinical question, not a pricing one. SURMOUNT-5 reported greater mean weight reduction on tirzepatide over 72 weeks, which is the strongest direct evidence available; semaglutide carries the larger cardiovascular outcomes base. If cost is the binding constraint, the cheaper molecule you can sustain for three years is a better bet than the dearer one you stop after eight months, because weight returns when either drug stops.

Who fills a Lavender Sky Health prescription

Lavender Sky Health does not name the dispensing pharmacy before purchase. That is common and it is not by itself a red flag, but it removes the only verification a patient can perform independently: checking the licence on a state board register.

If you enrol, ask in writing which pharmacy will fill the prescription, whether it is a 503A compounder or a 503B outsourcing facility, and request the certificate of analysis for your lot. A programme unwilling to answer those three questions in writing has told you something.

The pharmacology behind the fees

Tirzepatide is dosed weekly, ships refrigerated and must not freeze. Those three facts explain most of the fee structures in this market. Weekly dosing means monthly fulfilment cycles and recurring shipping. Refrigeration means insulated packaging, coolant and expedited carriage. Not freezing means the winter and summer failure modes are different and both cost money to mitigate.

A programme charging nothing for shipping has absorbed that cost into the medication price rather than eliminated it. A programme itemising it has not necessarily made you worse off. The only comparison that survives either structure is the all-in monthly figure, which is why it is the only figure this site ranks on.

What stopping does, and why it belongs in a cost calculation

The withdrawal evidence for this drug class is consistent: substantial weight regain follows discontinuation, because the drug suppresses appetite while it is being taken rather than resetting a set point. That is a pharmacological property, not a failure of willpower.

Read as a budgeting question, it means the relevant number is not what a first year costs but what a sustainable year costs, repeated. A programme you can afford for three years at a maintenance dose is a better clinical bet than one you can afford for eight months, even if the second is cheaper on the month you enrol.

Why the same molecule sells across a fifteenfold range

The active ingredient is identical whether it arrives as Zepbound at list price or as a compounded preparation at $215 a month. What differs is everything around it: pre-market review, manufacturing under a federal quality system, supply-chain traceability, cold-chain validation, pharmacovigilance and the commercial cost of bringing a drug to market at all.

That is the trade a compounded route asks you to make, and it is a real one in both directions. The approved product carries assurances the compounded one does not. The compounded one is accessible to people for whom the approved product is not, which is not a trivial benefit when the alternative is no treatment.

What is not defensible is presenting the two as equivalent. A compounded preparation is not a cheaper version of Zepbound; it is a different regulatory object containing the same molecule.